Boehringer Ingelheim Competitors and Similar CompaniesClear all
Daiichi Sankyo's competitors and similar companies include Pfizer and Zoetis.
 Daiichi Sankyo Daiichi Sankyo (第一三共株式会社) is a company specializing in the research, development, and manufacture of innovative pharmaceutical products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Zoetis Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services. | |
Founding Date | Founding Date 2005 | Founding Date 1849 | Founding Date 1952 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Braine L'alleud, BE Sao Paulo, BR Toronto, CA Shanghai, CN see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Parsippany, US HQ Buenos Aires, AR Villa Adelina, AR Silverwater, AU Wien, AT Ottignies Louvain La Neuve, BE Zaventem, BE see more |
Employees | Employees 18,726 | Employees 81,0008% decrease | Employees 14,1002% increase |
Valuation ($) | Valuation ($) 61.7 b | Valuation ($) 163.9 b | Valuation ($) 82.1 b |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.9t (FY, 2024) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $9.5b (FY, 2025) |
Cost of goods | Cost of goods ¥415.8b (FY, 2024) | Cost of goods $16.1b (FY, 2025) | Cost of goods $2.7b (FY, 2025) |
Gross profit | Gross profit ¥1.5t (FY, 2024) | Gross profit $46.5b (FY, 2025) | Gross profit $6.8b (FY, 2025) |
Net income | Net income ¥295.8b (FY, 2024) | Net income $7.8b (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Countries | Countries N/A | Countries 200 (FY, 2024) | Countries 100 (Q3, 2021) |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites 37 (FY, 2024) | Manufacturing Sites 29 (FY, 2020) |
Patent Applications | Patent Applications 367 (Jun, 2022) | Patent Applications N/A | Patent Applications 1.5 k (FY, 2020) |
Phase I Trials Products | Phase I Trials Products 16 (FY, 2018) | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 7 (FY, 2018) | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 7 (FY, 2018) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A |
Trademarks | Trademarks 112 (Jun, 2022) | Trademarks N/A | Trademarks 8.2 k (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyZoetis
HQ
Parsippany, US
Employees
14,100↑ 2% increase
Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services.
View company